ROCKVILLE, Md., March 25, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), announced today that the Company entered into a securities purchase agreement with David E. Lazar, an experienced private investor, pursuant to which he will acquire 3,000,000 shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) of the Company at a price of $1.00 per share for aggregate gross proceeds of $3.0 million.
Long before SPACs became a big hit on Wall St. there were “ordinary” Reverse Mergers on the Nasdaq & NYSE with small operating companies that no longer had a need to be public.
Read MoreSo before we begin let’s start by defining a few key terms: 1. S-1 is a registration statement filing that gets submitted for examination and final approval by the SEC. Once approved the company can raise money based upon the terms set forth within the S-1 (i.e.) minimum/maximum of…
Read More